These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18584549)

  • 21. Influenza vaccine-associated adverse events: results of passive surveillance, Canada 2001-2002.
    Choudhri Y; Walop W
    Can Commun Dis Rep; 2002 Dec; 28(23):189-96. PubMed ID: 12501745
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute meningoencephalitis after influenza vaccination].
    Chhor V; Lescot T; Lerolle N; Tadié JM; Guérot E
    Ann Fr Anesth Reanim; 2008 Feb; 27(2):169-71. PubMed ID: 18242947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community acquired influenza requiring hospitalization: vaccine status is unrelated to morbidity in children with cancer.
    Kersun LS; Coffin SE; Leckerman KH; Ingram M; Reilly AF
    Pediatr Blood Cancer; 2010 Jan; 54(1):79-82. PubMed ID: 19743304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The time has come to change the influenza vaccination strategy].
    Kiro A; Mor Z
    Harefuah; 2008 Dec; 147(12):993-4, 1028. PubMed ID: 19260598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children.
    Esposito S; Pelucchi C; Tel F; Chiarelli G; Sabatini C; Semino M; Marseglia GL; De Mattia D; Principi N
    Vaccine; 2009 Jan; 27(5):633-5. PubMed ID: 19056445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccination coverage among children aged 6 months--18 years - eight immunization information system sentinel sites, United States, 2008-09 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(38):1059-62. PubMed ID: 19798018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.
    Evison J; Farese S; Seitz M; Uehlinger DE; Furrer H; Mühlemann K
    Clin Infect Dis; 2009 May; 48(10):1402-12. PubMed ID: 19361304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate of influenza vaccination and its adverse reactions seen in health care personnel in a single tertiary hospital in Korea.
    Lee CS; Lee KH; Jung MH; Lee HB
    Jpn J Infect Dis; 2008 Nov; 61(6):457-60. PubMed ID: 19050354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination-related adverse events.
    Babl FE; Lewena S; Brown L
    Pediatr Emerg Care; 2006 Jul; 22(7):514-9; quiz 520-2. PubMed ID: 16871116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health benefits, risks, and cost-effectiveness of influenza vaccination in children.
    Fleming DM; Elliot AJ
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S154-8. PubMed ID: 18955891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection.
    Finelli L; Fiore A; Dhara R; Brammer L; Shay DK; Kamimoto L; Fry A; Hageman J; Gorwitz R; Bresee J; Uyeki T
    Pediatrics; 2008 Oct; 122(4):805-11. PubMed ID: 18829805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).
    Doroshenko A; Halperin SA
    Expert Rev Vaccines; 2009 Jun; 8(6):679-88. PubMed ID: 19485748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported influenza vaccination rates among health care workers in a large health system.
    Nowalk MP; Lin CJ; Zimmerman RK; Fox DE; Raymund M; Tanis MD; Harper JD; Willis BC
    Am J Infect Control; 2008 Oct; 36(8):574-81. PubMed ID: 18926311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging data on the safety and efficacy of influenza vaccines in children.
    Vesikari T
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
    Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ
    J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.